TMCnet - World's Largest Communications and Technology Community



Traders Get Bullish on Shares of ImmunoCellular Therapeutics, Shares Up 5.7% (IMUC)
[January 16, 2013]

Traders Get Bullish on Shares of ImmunoCellular Therapeutics, Shares Up 5.7% (IMUC)

Jan 16, 2013 (SmarTrend(R) Spotlight via COMTEX) -- ImmunoCellular Therapeutics (NASDAQ:IMUC) is one of today's best performing low-priced stocks, up 5.7% to $2.25 on 1.1x average daily volume. ImmunoCellular Therapeutics has traded 457,000 shares thus far today, vs. average volume of 400,000 shares per day. The stock has outperformed the Dow (5.7% to the Dow's -0.3%) and outperformed the S&P 500 (5.7% to the S&P's -0.2%) during today's trading.

ImmunoCellular Therapeutics (NASDAQ:IMUC) has potential upside of 316.6% based on a current price of $2.25 and analysts' consensus price target of $9.38. ImmunoCellular Therapeutics shares should encounter resistance at the 200-day moving average (MA) of $2.70 and support at the 50-day MA of $1.97.

ImmunoCellular Therapeutics, Ltd. is a development stage company that seeks to develop imaging devices with medical diagnostic applications.

In the past 52 weeks, shares of ImmunoCellular Therapeutics have traded between a low of $0.98 and a high of $4.00 and are now at $2.25, which is 130% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has advanced 0.7%.

SmarTrend is tracking the current trend status for ImmunoCellular Therapeutics and will alert subscribers who have IMUC in their portfolio or watchlist when shares have changed trend direction.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy